GLP-1 Agonist Tablet is an investigational, orally active small-molecule compound that functions as a non-peptide agonist of the glucagon-like peptide-1 (GLP-1) receptor. In research settings, it is utilized to examine mechanisms of incretin signaling, glucose homeostasis, and receptor-mediated metabolic pathways. Its non-peptide structure supports in vitro and in vivo studies focused on GLP-1 receptor activity and downstream signaling dynamics.















